Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21543930rdf:typepubmed:Citationlld:pubmed
pubmed-article:21543930lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:21543930lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:21543930lifeskim:mentionsumls-concept:C0814225lld:lifeskim
pubmed-article:21543930lifeskim:mentionsumls-concept:C1521721lld:lifeskim
pubmed-article:21543930lifeskim:mentionsumls-concept:C1096776lld:lifeskim
pubmed-article:21543930lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:21543930lifeskim:mentionsumls-concept:C0205547lld:lifeskim
pubmed-article:21543930lifeskim:mentionsumls-concept:C0013331lld:lifeskim
pubmed-article:21543930lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:21543930pubmed:issue4lld:pubmed
pubmed-article:21543930pubmed:dateCreated2011-5-5lld:pubmed
pubmed-article:21543930pubmed:abstractTextRoutine follow-up is standard medical practice in ovarian cancer patients treated with curative intent. However, no strong evidence exists indicating that prognosis is improved. The objective of this study was to evaluate the routine follow-up schedule for ovarian cancer patients regarding the adherence to the Dutch protocol, the detection of recurrences, and the follow-up's impact on overall survival.lld:pubmed
pubmed-article:21543930pubmed:languageenglld:pubmed
pubmed-article:21543930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21543930pubmed:citationSubsetIMlld:pubmed
pubmed-article:21543930pubmed:statusMEDLINElld:pubmed
pubmed-article:21543930pubmed:monthMaylld:pubmed
pubmed-article:21543930pubmed:issn1525-1438lld:pubmed
pubmed-article:21543930pubmed:authorpubmed-author:VerbeekAndré...lld:pubmed
pubmed-article:21543930pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:21543930pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:21543930pubmed:authorpubmed-author:Tjan-HeijnenV...lld:pubmed
pubmed-article:21543930pubmed:authorpubmed-author:MassugerLeon...lld:pubmed
pubmed-article:21543930pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:21543930pubmed:authorpubmed-author:GeurtsSandra...lld:pubmed
pubmed-article:21543930pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21543930pubmed:volume21lld:pubmed
pubmed-article:21543930pubmed:ownerNLMlld:pubmed
pubmed-article:21543930pubmed:authorsCompleteYlld:pubmed
pubmed-article:21543930pubmed:pagination647-53lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:meshHeadingpubmed-meshheading:21543930...lld:pubmed
pubmed-article:21543930pubmed:year2011lld:pubmed
pubmed-article:21543930pubmed:articleTitleNo supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.lld:pubmed
pubmed-article:21543930pubmed:affiliationDepartment of Epidemiology, Biostatistics, and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. S.Geurts@ebh.umcn.nllld:pubmed
pubmed-article:21543930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21543930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21543930pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:21543930pubmed:publicationTypeEvaluation Studieslld:pubmed